Skip to main content
Caplight Logo









Zorion Medical

Zorion Medical

Private
Zionsville, IndianaHealthcare & Life Scienceshttps://zorionmedical.net

Last Round

Series A

Jan 1, 2023

Total Funding Raised

$2.86M

Company Overview

Zorion Medical is a therapeutic devices company that develops absorbable drug-eluting stents to treat cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

absorbable vascular scaffoldbioresorbable vascular scaffolddissolving stentbioabsorbable stentbio-metal alloyperipheral artery diseasePADinterventional cardiologyself-expanding stentdrug-eluting stentDESvascular implantclinical trialsmedical deviceadvanced materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zorion Medical Comparables

Compare Zorion Medical with similar companies based on industry and business-model similarity.

Zorion Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elixir Medical Corporation
86%
R3 Vascular Inc.
84%
REVA Medical
83%

Zorion Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 1, 2023
SeedOct 20, 2011

Zorion Medical Investors

Notable investors and investment history

Zorion Medical investors
InvestorRounds
Elevate VenturesSeries A
BioCrossroadsSeed
Periculum CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2023

    Raised $3M with participation from Elevate Ventures and Periculum Capital.

  • Oct 20, 2011

    $360K round from BioCrossroads Indiana Seed Fund I and Periculum Capital

Zorion Medical Filings

Explore SEC and related filing metadata, where available.

Zorion Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zorion Medical's valuation, stock price, and market status.

Is Zorion Medical a public or private company?

Zorion Medical is a private company.

What is the current stock price of Zorion Medical?

Zorion Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Zorion Medical worth (valuation)?

Valuation information for Zorion Medical is not publicly available.

Can I buy Zorion Medical stock?

Zorion Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zorion Medical's last funding round?

Zorion Medical's most recent funding round was Series A on January 1, 2023.

Who are the main investors in Zorion Medical?

Key investors in Zorion Medical include Elevate Ventures, BioCrossroads, Periculum Capital.

Will Zorion Medical IPO soon?

No public IPO plans have been announced for Zorion Medical.

How can I track Zorion Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zorion Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZionsville, Indiana
Year Founded2010
Last FundingJan 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?